• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性髓系白血病中的核孔蛋白214

NUP214 in Acute Myeloid Leukemia.

作者信息

Bruserud Øystein, Reikvam Håkon

机构信息

Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5007 Bergen, Norway.

Section for Hematology, Department of Medicine, Haukeland University Hospital, 5009 Bergen, Norway.

出版信息

Cells. 2025 Sep 18;14(18):1461. doi: 10.3390/cells14181461.

DOI:10.3390/cells14181461
PMID:41002427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12468270/
Abstract

Nucleoporin 214 (NUP214) is a component of the nucleopore molecular complex, but in addition to this role in nucleocytoplasmic transport it is also involved in the regulation of gene transcription/translation, intracellular signaling, cell cycle progression and programmed cell death. Several uncommon translocations associated with acute myeloid leukemia (AML) involve the gene, and the corresponding fusion proteins are involved in leukemic transformation. First, the t(6;9) translocation encodes the DEK-NUP214 fusion protein; this translocation is seen in 1-2% of AML patients and is associated with an adverse prognosis that is improved by allogeneic stem cell transplantation. Second, the fusion gene is less common in AML and is formed either by del(9)(q34.11q34.13) or a balanced t(9;9)(q34;q34). This AML variant shows several biological similarities with the variant, but the possible prognostic impact of this fusion protein is not known. Finally, the and especially the fusions are very uncommon, and only a few case reports have been published. In this article, we review the functions of the genes/proteins formed by these fusion genes, the available studies of molecular mechanisms and biological functions for each fusion protein, the characteristics of the corresponding AML cells, the clinical characteristics of these patients and the possible prognostic impact of the fusion genes/proteins.

摘要

核孔蛋白214(NUP214)是核孔分子复合物的一个组成部分,但除了在核质运输中发挥这一作用外,它还参与基因转录/翻译的调控、细胞内信号传导、细胞周期进程和程序性细胞死亡。几种与急性髓系白血病(AML)相关的罕见易位涉及该基因,相应的融合蛋白参与白血病转化。首先,t(6;9)易位编码DEK-NUP214融合蛋白;这种易位见于1%-2%的AML患者,与不良预后相关,而异基因干细胞移植可改善这种预后。其次,该融合基因在AML中较少见,由del(9)(q34.11q34.13)或平衡的t(9;9)(q34;q34)形成。这种AML变异型与该变异型表现出一些生物学相似性,但这种融合蛋白可能的预后影响尚不清楚。最后,该融合尤其是该融合非常罕见,仅发表了少数病例报告。在本文中,我们综述了这些融合基因形成的基因/蛋白的功能、每种融合蛋白的分子机制和生物学功能的现有研究、相应AML细胞的特征、这些患者的临床特征以及融合基因/蛋白可能的预后影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/8643865ca3ea/cells-14-01461-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/34b2a1744e08/cells-14-01461-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/b7b14851e40b/cells-14-01461-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/b1dfd4ca6823/cells-14-01461-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/e8ed5010fb3b/cells-14-01461-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/8643865ca3ea/cells-14-01461-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/34b2a1744e08/cells-14-01461-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/b7b14851e40b/cells-14-01461-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/b1dfd4ca6823/cells-14-01461-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/e8ed5010fb3b/cells-14-01461-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12468270/8643865ca3ea/cells-14-01461-g005.jpg

相似文献

1
NUP214 in Acute Myeloid Leukemia.急性髓系白血病中的核孔蛋白214
Cells. 2025 Sep 18;14(18):1461. doi: 10.3390/cells14181461.
2
SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.急性髓系白血病和 T 细胞急性淋巴细胞白血病源性细胞系中的 SET-NUP214 融合。
J Hematol Oncol. 2009 Jan 23;2:3. doi: 10.1186/1756-8722-2-3.
3
monitoring before and after allogeneic haematopoietic stem cell transplantation for acute myeloid leukemia: A report from the TROPHY study group.急性髓系白血病异基因造血干细胞移植前后的监测:TROPHY研究组报告
J Transl Int Med. 2025 Jul 31;13(4):375-385. doi: 10.1515/jtim-2025-0032. eCollection 2025 Aug.
4
Unfavorable disease progression in patients with chronic myeloid leukemia and concurrent t(6;9) translocation (DEK::NUP214 fusion) or inversion 16 (CBFB::MYH11 fusion).慢性粒细胞白血病合并t(6;9)易位(DEK::NUP214融合)或16号染色体倒位(CBFB::MYH11融合)患者的不良疾病进展。
Cancer Genet. 2025 Aug 16;298-299:20-26. doi: 10.1016/j.cancergen.2025.08.004.
5
Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases.伴 t(6;9)(p22;q34.1)/DEK-NUP214 骨髓增生异常综合征是否应更好地归类为急性髓系白血病?107 例多中心研究。
Mod Pathol. 2021 Jun;34(6):1143-1152. doi: 10.1038/s41379-021-00741-w. Epub 2021 Feb 8.
6
AML1-ETO and CCND2 overexpression cooperate to drive acute myeloid leukemia initiation and progression.AML1-ETO与CCND2的过表达协同作用,驱动急性髓系白血病的起始和进展。
J Leukoc Biol. 2025 Jun 4;117(6). doi: 10.1093/jleuko/qiaf072. Epub 2025 May 22.
7
The characteristics and prognostic significance of the SET-CAN/NUP214 fusion gene in hematological malignancies: A systematic review.SET-CAN/NUP214 融合基因在血液系统恶性肿瘤中的特征及预后意义:系统评价。
Medicine (Baltimore). 2022 Jul 29;101(30):e29294. doi: 10.1097/MD.0000000000029294.
8
A systematic overview of chemotherapy effects in acute myeloid leukaemia.急性髓系白血病化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):231-52. doi: 10.1080/02841860151116321.
9
Vesicoureteral Reflux膀胱输尿管反流
10
-Fusion Identified by RNA-Sequencing of an Acute Myeloid Leukemia with t(9;12)(q34;q15).- 通过RNA测序在伴有t(9;12)(q34;q15)的急性髓系白血病中鉴定出融合现象
Cancer Genomics Proteomics. 2017 Nov-Dec;14(6):437-443. doi: 10.21873/cgp.20053.

本文引用的文献

1
NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World Study.NUP98重排动力学预测接受异基因造血干细胞移植的成年急性髓系白血病患者的预后:一项多中心真实世界研究
Transplant Cell Ther. 2025 Aug 5. doi: 10.1016/j.jtct.2025.07.012.
2
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.DEK::NUP214作为必需白血病基因的一种依赖XPO1的转录激活因子发挥作用。
Leukemia. 2025 Apr 9. doi: 10.1038/s41375-025-02593-8.
3
HoxBlinc: a key driver of chromatin dynamics in NUP98 fusion-driven leukemia.
HoxBlinc:NUP98融合驱动型白血病中染色质动力学的关键驱动因素。
J Clin Invest. 2025 Apr 1;135(7):e191355. doi: 10.1172/JCI191355.
4
XPO1-dependency of DEK::NUP214 leukemia.DEK::NUP214白血病对XPO1的依赖性
Leukemia. 2025 May;39(5):1102-1113. doi: 10.1038/s41375-025-02570-1. Epub 2025 Mar 27.
5
Acute myeloid leukemia with fusion resembling acute promyelocytic leukemia, initially presenting as sweet syndrome: A case report and literature review.伴有类似急性早幼粒细胞白血病融合基因的急性髓系白血病,初发表现为Sweet综合征:一例报告及文献复习
J Int Med Res. 2025 Mar;53(3):3000605251327476. doi: 10.1177/03000605251327476. Epub 2025 Mar 26.
6
XPO1/Exportin-1 in Acute Myelogenous Leukemia; Biology and Therapeutic Targeting.急性髓系白血病中的XPO1/输出蛋白1;生物学特性与治疗靶点
Biomolecules. 2025 Jan 24;15(2):175. doi: 10.3390/biom15020175.
7
Structural insights into how DEK nucleosome binding facilitates H3K27 trimethylation in chromatin.DEK核小体结合如何促进染色质中H3K27三甲基化的结构见解。
Nat Struct Mol Biol. 2025 Feb 21. doi: 10.1038/s41594-025-01493-w.
8
FLT3 inhibitors induce p53 instability, driven by STAT5/MDM2/p53 competitive interactions in acute myeloid leukemia.在急性髓系白血病中,FLT3抑制剂通过STAT5/MDM2/p53竞争性相互作用诱导p53不稳定。
Cancer Lett. 2025 Jan 3;611:217446. doi: 10.1016/j.canlet.2025.217446.
9
The Potential of Nuclear Pore Complexes in Cancer Therapy.核孔复合体在癌症治疗中的潜力。
Molecules. 2024 Oct 12;29(20):4832. doi: 10.3390/molecules29204832.
10
NPM1-fusion proteins promote myeloid leukemogenesis through XPO1-dependent HOX activation.核仁磷酸蛋白1融合蛋白通过依赖于核输出蛋白1的同源盒基因激活促进髓系白血病发生。
Leukemia. 2025 Jan;39(1):75-86. doi: 10.1038/s41375-024-02438-w. Epub 2024 Oct 23.